EDIT
Editas Medicine, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.70
−0.74%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.21
- Revenue estimate
- $4.5M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.15
- EPS estimate
- -$0.27
- Revenue actual
- $11.9M
- Revenue estimate
- $2.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +22.8%
- Revenue beats (12Q)
- 9
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.27 | -$0.15 | Beat 44.55% | $11.9M |
| May 5, 2026 | -$0.30 | -$0.26 | Beat 13.33% | $2.8M |
| Mar 9, 2026 | -$0.23 | -$0.06 | Beat 74.21% | $24.7M |
| Mar 5, 2025 | -$0.39 | -$0.55 | Miss -41.03% | $30.6M |
| Feb 28, 2024 | -$0.52 | -$0.23 | Beat 55.77% | $60.0M |
| Nov 3, 2023 | -$0.64 | -$0.55 | Beat 14.06% | $5.3M |
| Aug 2, 2023 | -$0.76 | -$0.56 | Beat 26.32% | $2.9M |
| May 5, 2023 | -$0.79 | -$0.71 | Beat 10.13% | $9.9M |
| Feb 22, 2023 | -$0.84 | -$0.88 | Miss -4.76% | $6.5M |
| Nov 2, 2022 | -$0.87 | -$0.81 | Beat 6.90% | — |
| Aug 3, 2022 | -$0.84 | -$0.78 | Beat 7.14% | $6.4M |
| May 4, 2022 | -$0.81 | -$0.74 | Beat 8.64% | $6.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026